GSK Plummets To 10-Month Low As RSV, Shingles Vaccines Hit The Skids
Investor's Business DailyGSK stock plunged Wednesday after sales of its RSV vaccine, Arexvy, skidded and widely missed Wall Street’s expectations.
The post GSK Plummets To 10-Month Low As RSV, Shingles Vaccines Hit The Skids appeared first on Investor's Business Daily.